APO Research
Talk to an analyst

APO RESEARCH · REPORT

IL-4Rα Monoclonal Antibody Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global IL-4Rα Monoclonal Antibody Drug Industry Growth and Trends Forecast to 2032

28 December 202578 pages

Choose your research edition.

Industry ResearchIL-4Rα Monoclonal Antibody Drug Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal IL-4Rα Monoclonal Antibody Drug Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal IL-4Rα Monoclonal Antibody Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IL-4Rα Monoclonal Antibody Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal IL-4Rα Monoclonal Antibody Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global IL-4Rα Monoclonal Antibody Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for IL-4Rα Monoclonal Antibody Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for IL-4Rα Monoclonal Antibody Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IL-4Rα Monoclonal Antibody Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of IL-4Rα Monoclonal Antibody Drug include Regeneron and Sanofi among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global IL-4Rα Monoclonal Antibody Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The IL-4Rα Monoclonal Antibody Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global IL-4Rα Monoclonal Antibody Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to IL-4Rα Monoclonal Antibody Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global IL-4Rα Monoclonal Antibody Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

IL-4Rα Monoclonal Antibody Drug Market by Company

Regeneron

Sanofi

IL-4Rα Monoclonal Antibody Drug Segment by Type

200mg (1.14mL)/Vial

300mg (2.0 mL)/Vial

IL-4Rα Monoclonal Antibody Drug Segment by Application

Asthma

Atopic Dermatitis

Chronic Sinusitis with Nasal Polyps

Other

IL-4Rα Monoclonal Antibody Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IL-4Rα Monoclonal Antibody Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IL-4Rα Monoclonal Antibody Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IL-4Rα Monoclonal Antibody Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of IL-4Rα Monoclonal Antibody Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of IL-4Rα Monoclonal Antibody Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 200mg (1.14mL)/Vial Table 2. Major Company of 300mg (2.0 mL)/Vial Table 3. Global IL-4Rα Monoclonal Antibody Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global IL-4Rα Monoclonal Antibody Drug Sales by Type (2021-2026) & (K Units) Table 5. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global IL-4Rα Monoclonal Antibody Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global IL-4Rα Monoclonal Antibody Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global IL-4Rα Monoclonal Antibody Drug Sales by Type (2027-2032) & (K Units) Table 10. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global IL-4Rα Monoclonal Antibody Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global IL-4Rα Monoclonal Antibody Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America IL-4Rα Monoclonal Antibody Drug Sales by Type (2021-2026) & (K Units) Table 15. North America IL-4Rα Monoclonal Antibody Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe IL-4Rα Monoclonal Antibody Drug Sales by Type (2021-2026) & (K Units) Table 17. Europe IL-4Rα Monoclonal Antibody Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America IL-4Rα Monoclonal Antibody Drug Sales by Type (2021-2026) & (K Units) Table 21. Latin America IL-4Rα Monoclonal Antibody Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales by Type (2021-2026) & (US$ Million) Table 24. IL-4Rα Monoclonal Antibody Drug Industry Trends Table 25. IL-4Rα Monoclonal Antibody Drug Industry Drivers Table 26. IL-4Rα Monoclonal Antibody Drug Industry Opportunities and Challenges Table 27. IL-4Rα Monoclonal Antibody Drug Industry Restraints Table 28. Global IL-4Rα Monoclonal Antibody Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Company (2021-2026) Table 30. Global IL-4Rα Monoclonal Antibody Drug Sales by Company (2021-2026) & (K Units) Table 31. Global IL-4Rα Monoclonal Antibody Drug Sales Share by Company (2021-2026) Table 32. Global IL-4Rα Monoclonal Antibody Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global IL-4Rα Monoclonal Antibody Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global IL-4Rα Monoclonal Antibody Drug Major Company Production Sites and Headquarters Table 35. Global IL-4Rα Monoclonal Antibody Drug Company, Product Type & Application Table 36. Global IL-4Rα Monoclonal Antibody Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global IL-4Rα Monoclonal Antibody Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global IL-4Rα Monoclonal Antibody Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global IL-4Rα Monoclonal Antibody Drug Sales by Region (2021-2026) & (K Units) Table 41. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global IL-4Rα Monoclonal Antibody Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global IL-4Rα Monoclonal Antibody Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global IL-4Rα Monoclonal Antibody Drug Sales by Region (2027-2032) & (K Units) Table 46. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global IL-4Rα Monoclonal Antibody Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global IL-4Rα Monoclonal Antibody Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global IL-4Rα Monoclonal Antibody Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global IL-4Rα Monoclonal Antibody Drug Sales by Application (2021-2026) & (K Units) Table 52. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global IL-4Rα Monoclonal Antibody Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global IL-4Rα Monoclonal Antibody Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global IL-4Rα Monoclonal Antibody Drug Sales by Application (2027-2032) & (K Units) Table 57. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global IL-4Rα Monoclonal Antibody Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global IL-4Rα Monoclonal Antibody Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America IL-4Rα Monoclonal Antibody Drug Sales by Application (2021-2026) & (K Units) Table 62. North America IL-4Rα Monoclonal Antibody Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe IL-4Rα Monoclonal Antibody Drug Sales by Application (2021-2026) & (K Units) Table 64. Europe IL-4Rα Monoclonal Antibody Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America IL-4Rα Monoclonal Antibody Drug Sales by Application (2021-2026) & (K Units) Table 68. Latin America IL-4Rα Monoclonal Antibody Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Regeneron Company Information Table 72. Regeneron Business Overview Table 73. Regeneron IL-4Rα Monoclonal Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Regeneron IL-4Rα Monoclonal Antibody Drug Product Portfolio Table 75. Regeneron Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi IL-4Rα Monoclonal Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sanofi IL-4Rα Monoclonal Antibody Drug Product Portfolio Table 80. Sanofi Recent Development Table 81. North America IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 82. North America IL-4Rα Monoclonal Antibody Drug Sales by Country (2021-2026) & (K Units) Table 83. North America IL-4Rα Monoclonal Antibody Drug Sales Market Share by Country (2021-2026) Table 84. North America IL-4Rα Monoclonal Antibody Drug Sales Forecast by Country (2027-2032) & (K Units) Table 85. North America IL-4Rα Monoclonal Antibody Drug Sales Market Share Forecast by Country (2027-2032) Table 86. North America IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 87. North America IL-4Rα Monoclonal Antibody Drug Market Size by Country (2021-2026) & (US$ Million) Table 88. North America IL-4Rα Monoclonal Antibody Drug Market Share by Country (2021-2026) Table 89. North America IL-4Rα Monoclonal Antibody Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 90. North America IL-4Rα Monoclonal Antibody Drug Market Share Forecast by Country (2027-2032) Table 91. Europe IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. Europe IL-4Rα Monoclonal Antibody Drug Sales by Country (2021-2026) & (K Units) Table 93. Europe IL-4Rα Monoclonal Antibody Drug Sales Market Share by Country (2021-2026) Table 94. Europe IL-4Rα Monoclonal Antibody Drug Sales Forecast by Country (2027-2032) & (K Units) Table 95. Europe IL-4Rα Monoclonal Antibody Drug Sales Market Share Forecast by Country (2027-2032) Table 96. Europe IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. Europe IL-4Rα Monoclonal Antibody Drug Market Size by Country (2021-2026) & (US$ Million) Table 98. Europe IL-4Rα Monoclonal Antibody Drug Market Share by Country (2021-2026) Table 99. Europe IL-4Rα Monoclonal Antibody Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. Europe IL-4Rα Monoclonal Antibody Drug Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales by Country (2021-2026) & (K Units) Table 103. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales Market Share by Country (2021-2026) Table 104. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales Forecast by Country (2027-2032) & (K Units) Table 105. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Market Size by Country (2021-2026) & (US$ Million) Table 108. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Market Share by Country (2021-2026) Table 109. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Market Share Forecast by Country (2027-2032) Table 111. Latin America IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Latin America IL-4Rα Monoclonal Antibody Drug Sales by Country (2021-2026) & (K Units) Table 113. Latin America IL-4Rα Monoclonal Antibody Drug Sales Market Share by Country (2021-2026) Table 114. Latin America IL-4Rα Monoclonal Antibody Drug Sales Forecast by Country (2027-2032) & (K Units) Table 115. Latin America IL-4Rα Monoclonal Antibody Drug Sales Market Share Forecast by Country (2027-2032) Table 116. Latin America IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Latin America IL-4Rα Monoclonal Antibody Drug Market Size by Country (2021-2026) & (US$ Million) Table 118. Latin America IL-4Rα Monoclonal Antibody Drug Market Share by Country (2021-2026) Table 119. Latin America IL-4Rα Monoclonal Antibody Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Latin America IL-4Rα Monoclonal Antibody Drug Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales by Country (2021-2026) & (K Units) Table 123. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales Market Share by Country (2021-2026) Table 124. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales Forecast by Country (2027-2032) & (K Units) Table 125. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Market Size by Country (2021-2026) & (US$ Million) Table 128. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Market Share by Country (2021-2026) Table 129. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Market Share Forecast by Country (2027-2032) Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. IL-4Rα Monoclonal Antibody Drug Distributors List Table 134. IL-4Rα Monoclonal Antibody Drug Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. IL-4Rα Monoclonal Antibody Drug Image Figure 2. Global IL-4Rα Monoclonal Antibody Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IL-4Rα Monoclonal Antibody Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global IL-4Rα Monoclonal Antibody Drug Sales (2021-2032) & (K Units) Figure 5. 200mg (1.14mL)/Vial Image Figure 6. Global 200mg (1.14mL)/Vial Sales YoY Growth (2021-2032) & (K Units) Figure 7. 300mg (2.0 mL)/Vial Image Figure 8. Global 300mg (2.0 mL)/Vial Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global IL-4Rα Monoclonal Antibody Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global IL-4Rα Monoclonal Antibody Drug Market Share by Type 2025 VS 2032 Figure 11. North America IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 IL-4Rα Monoclonal Antibody Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Asthma Image Figure 24. Global Asthma Sales YoY Growth (2021-2032) & (K Units) Figure 25. Atopic Dermatitis Image Figure 26. Global Atopic Dermatitis Sales YoY Growth (2021-2032) & (K Units) Figure 27. Chronic Sinusitis with Nasal Polyps Image Figure 28. Global Chronic Sinusitis with Nasal Polyps Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global IL-4Rα Monoclonal Antibody Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global IL-4Rα Monoclonal Antibody Drug Market Share by Application 2025 VS 2032 Figure 33. North America IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales Market Share in Value by Application in 2025 Figure 43. North America IL-4Rα Monoclonal Antibody Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America IL-4Rα Monoclonal Antibody Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America IL-4Rα Monoclonal Antibody Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America IL-4Rα Monoclonal Antibody Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe IL-4Rα Monoclonal Antibody Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe IL-4Rα Monoclonal Antibody Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe IL-4Rα Monoclonal Antibody Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe IL-4Rα Monoclonal Antibody Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific IL-4Rα Monoclonal Antibody Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America IL-4Rα Monoclonal Antibody Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America IL-4Rα Monoclonal Antibody Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America IL-4Rα Monoclonal Antibody Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America IL-4Rα Monoclonal Antibody Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. IL-4Rα Monoclonal Antibody Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. IL-4Rα Monoclonal Antibody Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 200mg (1.14mL)/Vial
  • 300mg (2.0 mL)/Vial
Applications
  • Asthma
  • Atopic Dermatitis
  • Chronic Sinusitis with Nasal Polyps
  • Other
Companies covered
  • Regeneron
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global IL-4Rα Monoclonal Antibody Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global IL-4Rα Monoclonal Antibody Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 IL-4Rα Monoclonal Antibody Drug Market by Type
  6. 1.3.1 200mg (1.14mL)/Vial
  7. 1.3.2 300mg (2.0 mL)/Vial
  8. 1.4 Global IL-4Rα Monoclonal Antibody Drug Market Size by Type
  9. 1.4.1 Global IL-4Rα Monoclonal Antibody Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global IL-4Rα Monoclonal Antibody Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global IL-4Rα Monoclonal Antibody Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America IL-4Rα Monoclonal Antibody Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe IL-4Rα Monoclonal Antibody Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America IL-4Rα Monoclonal Antibody Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 IL-4Rα Monoclonal Antibody Drug Industry Trends
  2. 2.2 IL-4Rα Monoclonal Antibody Drug Industry Drivers
  3. 2.3 IL-4Rα Monoclonal Antibody Drug Industry Opportunities and Challenges
  4. 2.4 IL-4Rα Monoclonal Antibody Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by IL-4Rα Monoclonal Antibody Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by IL-4Rα Monoclonal Antibody Drug Sales (2021-2026)
  3. 3.3 Global Top Players by IL-4Rα Monoclonal Antibody Drug Price (2021-2026)
  4. 3.4 Global IL-4Rα Monoclonal Antibody Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global IL-4Rα Monoclonal Antibody Drug Major Company Production Sites & Headquarters
  6. 3.6 Global IL-4Rα Monoclonal Antibody Drug Company, Product Type & Application
  7. 3.7 Global IL-4Rα Monoclonal Antibody Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global IL-4Rα Monoclonal Antibody Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 IL-4Rα Monoclonal Antibody Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 IL-4Rα Monoclonal Antibody Drug Tier 1, Tier 2, and Tier 3
4 IL-4Rα Monoclonal Antibody Drug Regional Status and Outlook
  1. 4.1 Global IL-4Rα Monoclonal Antibody Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global IL-4Rα Monoclonal Antibody Drug Historic Market Size by Region
  3. 4.2.1 Global IL-4Rα Monoclonal Antibody Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global IL-4Rα Monoclonal Antibody Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global IL-4Rα Monoclonal Antibody Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global IL-4Rα Monoclonal Antibody Drug Forecasted Market Size by Region
  7. 4.3.1 Global IL-4Rα Monoclonal Antibody Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global IL-4Rα Monoclonal Antibody Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global IL-4Rα Monoclonal Antibody Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 IL-4Rα Monoclonal Antibody Drug by Application
  1. 5.1 IL-4Rα Monoclonal Antibody Drug Market by Application
  2. 5.1.1 Asthma
  3. 5.1.2 Atopic Dermatitis
  4. 5.1.3 Chronic Sinusitis with Nasal Polyps
  5. 5.1.4 Other
  6. 5.2 Global IL-4Rα Monoclonal Antibody Drug Market Size by Application
  7. 5.2.1 Global IL-4Rα Monoclonal Antibody Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global IL-4Rα Monoclonal Antibody Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global IL-4Rα Monoclonal Antibody Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America IL-4Rα Monoclonal Antibody Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe IL-4Rα Monoclonal Antibody Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America IL-4Rα Monoclonal Antibody Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Regeneron
  2. 6.1.1 Regeneron Company Information
  3. 6.1.2 Regeneron Business Overview
  4. 6.1.3 Regeneron IL-4Rα Monoclonal Antibody Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Regeneron IL-4Rα Monoclonal Antibody Drug Product Portfolio
  6. 6.1.5 Regeneron Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi IL-4Rα Monoclonal Antibody Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi IL-4Rα Monoclonal Antibody Drug Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America IL-4Rα Monoclonal Antibody Drug Sales by Country
  2. 7.1.1 North America IL-4Rα Monoclonal Antibody Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America IL-4Rα Monoclonal Antibody Drug Sales by Country (2021-2026)
  4. 7.1.3 North America IL-4Rα Monoclonal Antibody Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America IL-4Rα Monoclonal Antibody Drug Market Size by Country
  6. 7.2.1 North America IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America IL-4Rα Monoclonal Antibody Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America IL-4Rα Monoclonal Antibody Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe IL-4Rα Monoclonal Antibody Drug Sales by Country
  2. 8.1.1 Europe IL-4Rα Monoclonal Antibody Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe IL-4Rα Monoclonal Antibody Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe IL-4Rα Monoclonal Antibody Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe IL-4Rα Monoclonal Antibody Drug Market Size by Country
  6. 8.2.1 Europe IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe IL-4Rα Monoclonal Antibody Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe IL-4Rα Monoclonal Antibody Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales by Country
  2. 9.1.1 Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific IL-4Rα Monoclonal Antibody Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific IL-4Rα Monoclonal Antibody Drug Market Size by Country
  6. 9.2.1 Asia-Pacific IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific IL-4Rα Monoclonal Antibody Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific IL-4Rα Monoclonal Antibody Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America IL-4Rα Monoclonal Antibody Drug Sales by Country
  2. 10.1.1 South America IL-4Rα Monoclonal Antibody Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America IL-4Rα Monoclonal Antibody Drug Sales by Country (2021-2026)
  4. 10.1.3 South America IL-4Rα Monoclonal Antibody Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America IL-4Rα Monoclonal Antibody Drug Market Size by Country
  6. 10.2.1 South America IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America IL-4Rα Monoclonal Antibody Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America IL-4Rα Monoclonal Antibody Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales by Country
  2. 11.1.1 Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa IL-4Rα Monoclonal Antibody Drug Market Size by Country
  6. 11.2.1 Middle East and Africa IL-4Rα Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa IL-4Rα Monoclonal Antibody Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa IL-4Rα Monoclonal Antibody Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 IL-4Rα Monoclonal Antibody Drug Value Chain Analysis
  2. 12.1.1 IL-4Rα Monoclonal Antibody Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 IL-4Rα Monoclonal Antibody Drug Production Mode & Process
  7. 12.2 IL-4Rα Monoclonal Antibody Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 IL-4Rα Monoclonal Antibody Drug Distributors
  10. 12.2.3 IL-4Rα Monoclonal Antibody Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst